Pacific Biosciences plans to serve the LDT market
QIAGEN to debut new NGS chemistry
Company announcements and product introductions
Company announcements and product introductions
10X Genomics, Thermo Fisher Scientific and NanoString debut new products
Illumina instrument sales disappoint
Venlo, the Netherlands and Hilden, Germany 9/10/16; San Francisco, CA 9/9/16–The US District Court for the Northern District of California has granted Illumina’s motion for a preliminary injunction barring the sale of QIAGEN’s GeneReader NGS System and related products in the US. The ruling stems from a patent infringement suit brought in May by Illumina […]
Company Announcements and Product Introductions
Each year, IBO recognizes innovative and functional industrial design of analytical instruments, laboratory equipment (see page 6) and portable instrumentation (see page 7). The IBO Design Awards are based on the physical appearance and aesthetics of the product, not on technical performance or use. To qualify, the product must have begun shipping between August 1, […]
Company Announcements Illumina announced in May the registration of the MiSeqDx as a cleared IVD medical device in Australia. Illumina, Merck KGaA and Genea announced in June the formation of the Global Fertility Alliance for Excellence in Assisted Reproductive Treatment for advancing fertility technologies and processes within the assisted reproductive treatment lab, including greater standardization. […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.

